185 related articles for article (PubMed ID: 11238713)
21. Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro.
Chen A; Hu WW; Jiang XL; Potegal M; Li H
Psychopharmacology (Berl); 2017 Feb; 234(4):681-694. PubMed ID: 28028604
[TBL] [Abstract][Full Text] [Related]
22. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.
Battaglia G; Fornai F; Busceti CL; Aloisi G; Cerrito F; De Blasi A; Melchiorri D; Nicoletti F
J Neurosci; 2002 Mar; 22(6):2135-41. PubMed ID: 11896153
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
24. Group I metabotropic glutamate receptors control phosphorylation of CREB, Elk-1 and ERK via a CaMKII-dependent pathway in rat striatum.
Choe ES; Wang JQ
Neurosci Lett; 2001 Nov; 313(3):129-32. PubMed ID: 11682144
[TBL] [Abstract][Full Text] [Related]
25. Protein phosphatase 1 and 2A inhibitors prolong the switch in the control of glutamate release by group I metabotropic glutamate receptors: characterization of the inhibitory pathway.
Sistiaga A; Sánchez-Prieto J
J Neurochem; 2000 Oct; 75(4):1566-74. PubMed ID: 10987837
[TBL] [Abstract][Full Text] [Related]
26. The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl) pyridine decreases striatal VGlut2 expression in association with an attenuation of L-DOPA-induced dyskinesias.
Marin C; Bonastre M; Aguilar E; Jiménez A
Synapse; 2011 Oct; 65(10):1080-6. PubMed ID: 21484883
[TBL] [Abstract][Full Text] [Related]
27. Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum.
Domenici MR; Pepponi R; Martire A; Tebano MT; Potenza RL; Popoli P
J Neurochem; 2004 Sep; 90(5):1276-9. PubMed ID: 15312183
[TBL] [Abstract][Full Text] [Related]
28. Group II metabotropic glutamate receptor modulation of excitatory transmission in rat subthalamic nucleus.
Shen KZ; Johnson SW
J Physiol; 2003 Dec; 553(Pt 2):489-96. PubMed ID: 14500768
[TBL] [Abstract][Full Text] [Related]
29. Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Battaglia G; Busceti CL; Molinaro G; Biagioni F; Storto M; Fornai F; Nicoletti F; Bruno V
J Neurosci; 2004 Jan; 24(4):828-35. PubMed ID: 14749427
[TBL] [Abstract][Full Text] [Related]
30. Activation of lateral hypothalamic mGlu1 and mGlu5 receptors elicits feeding in rats.
Charles JR; Duva MA; Ramirez GJ; Lara RL; Yang CR; Stanley BG
Neuropharmacology; 2014 Apr; 79():59-65. PubMed ID: 24219858
[TBL] [Abstract][Full Text] [Related]
31. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
O'Leary DM; Movsesyan V; Vicini S; Faden AI
Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
[TBL] [Abstract][Full Text] [Related]
32. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of the actions of group I metabotropic glutamate receptor subtype selective ligands on excitatory amino acid release and sodium-dependent re-uptake in rat cerebrocortical minislices.
Fazal A; Parker F; Palmer AM; Croucher MJ
J Neurochem; 2003 Sep; 86(6):1346-58. PubMed ID: 12950444
[TBL] [Abstract][Full Text] [Related]
35. Modulation of intracellular calcium mobilization and GABAergic currents through subtype-specific metabotropic glutamate receptors in neonatal rat hippocampus.
Taketo M; Matsuda H
Brain Res Bull; 2010 Jan; 81(1):73-80. PubMed ID: 19628026
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of Na-K-2Cl cotransporter in neurons by activation of Non-NMDA ionotropic receptor and group-I mGluRs.
Schomberg SL; Su G; Haworth RA; Sun D
J Neurophysiol; 2001 Jun; 85(6):2563-75. PubMed ID: 11387401
[TBL] [Abstract][Full Text] [Related]
37. Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized rats.
Scheggi S; Crociani A; De Montis MG; Tagliamonte A; Gambarana C
Neuroscience; 2009 Oct; 163(2):627-39. PubMed ID: 19559764
[TBL] [Abstract][Full Text] [Related]
38. The mGluR5 antagonist MPEP elevates accumbal dopamine and glycine levels; interaction with strychnine-sensitive glycine receptors.
Chau P; Söderpalm B; Ericson M
Addict Biol; 2011 Oct; 16(4):591-9. PubMed ID: 21790901
[TBL] [Abstract][Full Text] [Related]
39. Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.
Luccini E; Musante V; Neri E; Brambilla Bas M; Severi P; Raiteri M; Pittaluga A
Br J Pharmacol; 2007 Aug; 151(7):1087-94. PubMed ID: 17592518
[TBL] [Abstract][Full Text] [Related]
40. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C.
Derbez AE; Mody RM; Werling LL
J Pharmacol Exp Ther; 2002 Apr; 301(1):306-14. PubMed ID: 11907188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
